The activation of MMP-9 was also correlated with EGFR expression in primary GBM tumors (tumors positive for EGFR, but negative for tumor suppressor protein p53), indicating a link between MMP-9 activation and molecular features of primary GBMs [28]. The gene discussed is MMP9; the disease is glioblastoma.